Document Detail


Bioprosthetic valve degeneration due to cholesterol deposition in a patient with normal lipid profile.
MedLine Citation:
PMID:  17347697     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypercholesterolemia has been identified as a risk factor for bioprosthetic valvular degeneration, and it has been suggested that statin therapy reduces this risk. The case of a 77-year-old man with low levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B who developed marked LDL-C crystal deposition and a severe foreign body giant cell reaction 21.5 years after aortic bioprosthetic replacement is reported. This observation confirms that cholesterol deposition contributes to bioprosthetic valve degeneration, but that this can occur even in patients with low levels of LDL-C. It suggests that the characteristics of the valve are more critical than the patient's level of LDL-C.
Authors:
Leslie Price; Allan Sniderman; Attila Omerglu; Kevin Lachapelle
Related Documents :
17359487 - Vascular stiffness in familial hypercholesterolaemia is associated with c-reactive prot...
15320837 - Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor?
20180777 - Obesity and arterial compliance alterations.
20409897 - Differential impact of heart rate on arterial wall stiffness and thickness in young adu...
21984027 - Limb outcome and mortality in lower and upper extremity arterial injury: a comparison u...
7283057 - Further experience with the saphenous vein used in situ for arterial bypass.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  23     ISSN:  0828-282X     ISO Abbreviation:  Can J Cardiol     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-09     Completed Date:  2007-04-20     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  233-4     Citation Subset:  IM    
Affiliation:
McGill University Health Centre, Montreal, Quebec.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aortic Valve Stenosis / surgery*
Apolipoproteins B / blood
Bioprosthesis*
Cholesterol, LDL / blood
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation / instrumentation
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hypercholesterolemia / blood*,  drug therapy
Male
Prosthesis Failure
Chemical
Reg. No./Substance:
0/Apolipoproteins B; 0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lithium-induced sinus node disease at therapeutic concentrations: linking lithium-induced blockade o...
Next Document:  Studying disorder in graphite-based systems by Raman spectroscopy.